| Institution: | 3. From the Department of Biology, Stanford University, Stanford, California 94305-5020,;4. the Department of Molecular and Cell Biology, University of California, Berkeley, California 94720-3202, and;5. the Department of Cell Biology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261;3. Laboratory of Cell Regulation, Department of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8521,;4. Nagasaki University Research Center for Genomic Instability and Carcinogenesis (NRGIC), Nagasaki 852-8523, and;5. Department of Genetic Biochemistry, Kyoto University Graduate School of Pharmaceutical Sciences, Kyoto 606-8501, Japan;1. Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721, USA;2. Laboratory of Biosignaling & Therapeutics, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium;1. Wellcome Trust Centre for Cell Biology, University of Edinburgh King’s Buildings, Max Born Crescent, Edinburgh EH9 3BF, UK |
